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In this issue of the Journal of Investigative Dermatology, Diaz
and coworkers report that a possible etiological link exists
between Fogo selvagem, an autoimmune disease, and pre-
vious exposure to the salivary antigens of blood-sucking in-
sects. Although the audience of this Journal may be well
acquainted with skin autoimmune diseases, the issue of in-
sect saliva may recall only annoying allergic responses to
unspecific antigens displayed by many patients. Why did
evolution develop salivary molecules that displease us, sub-
stances that should be counterproductive to insect feeding,
by eliciting the defense reactions of the insects prey? The
interplay of hematophagous arthropod salivary molecules
and their prey’s immune reaction is a problem that insects
have dealt with for at least 300 million years, well before we
mammals came to think we dominate the planet.
Insects are an extremely successful branch of animals,
able to exploit any kind of food source on land, including the
blood of vertebrates. The number of blood-sucking insect
species, well over 15,000, approaches the number of land
vertebrates. The vast number of insect families and orders
allowed hematophagy to evolve independently several times,
even within a single insect order, such as the Diptera or the
Hemiptera (Ribeiro, 1995). Ticks, which are spiders, not in-
sects, have also skillfully exploited this food resource. What
adaptations make a successful blood sucker?
In addition to having developed suitable mouthparts, the
behavioral adaptations to find their prey and digest their pe-
culiar meal, blood suckers had to solve the riddle posed by
the vertebrate hemostasis and inflammation processes. If
these problems were not dealt with, blood clotting would
prevent sucking blood, and local responses such as pain or
itching could lead to a fast termination of the meal, often with
death of the insect. Hemostasis and inflammation, including
the immune responses that alter the injury response, are
redundant mechanisms. Hemostasis results from the
combination of platelet aggregation, blood clotting and
vasoconstriction, each of these 3 phenomena being redun-
dant themselves, (e.g., platelets can be aggregated by sev-
eral stimuli using different receptors, blood clotting may be
initiated or regulated at several points in the clotting cascade,
and more than one vasoconstrictor (thromboxane A2 and
serotonin, for example) is involved in the vasoconstriction
arm of hemostasis). The inflammatory and the immune re-
sponses, in comparison, are of far more complex. Against
such a redundant problem, evolution shaped in the salivary
glands of blood sucking insects not a magic bullet, but rather
a magic potion containing several pharmacologically potent
molecules that disarm our attempts to prevent blood loss to
the hungry insect or tick. Indeed at least one platelet aggre-
gation inhibitor, one anti-clotting and one vasodilatory sub-
stance are found in the saliva of these animals. Because
many insects evolved independently to blood feeding, the
molecular composition of these potions is astounding. For
example, known salivary vasodilatory substances range from
nitric oxide to adenosine, prostaglandins E2 and F2a, pep-
tides of the tachykinin family, novel peptides acting on the
pituitary adenylate cyclase-activating polypeptide (PACAP)
and on unknown receptors, and catechol oxidases. Similarly,
many unrelated peptides have been characterized as inhib-
itors of blood clotting (Ribeiro and Francischetti, 2003), and
characterization of salivary immunomodulatory molecules,
mostly from ticks, is increasing (Schoeler and Wikel, 2001).
Furthermore, recent advances in transcriptome analysis are
uncovering a vast number of peptides that are thought to be
secreted in the saliva of blood sucking insects and ticks for
which we have no idea of their function, many of these
having domains found in extracellular matrix proteins and
similarities to angiopoietins or collagens (Ribeiro and
Francischetti, 2003). One thing we know for sure, these ar-
thropods use more pharmacology than we know about.
Against these wise pharmacologists, we vertebrates re-
spond with an immunological counterattack. If we succeed to
degranulate mast cells within 90 s of the initial bite, we may be
able to prevent, or most likely, postpone, the loss of some
microliters of blood or the inoculation of some harmful para-
site. We may also reduce the time taken by these persistent
feeders to obtain what they want from us, if we are able to
make rapidly neutralizing antibodies to most or all the com-
ponents of their redundant magic potion. Perhaps more im-
portantly, hypersensitivity to vector saliva may protect against
some vector-borne diseases (Bell et al, 1979; Valenzuela et al,
2001). In this anti-vector saliva response we may also create
antibodies to compounds that were shaped by evolution to act
on our own receptors, and, for this reason, are mimics of our
own molecules. It thus happens that in this immunopharma-
cological cross-fire, some of us may succumb to friendly fire.
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